SciELO - Scientific Electronic Library Online

 
vol.20 issue2Exclusive breastfeeding and associated factors in mothers who attend health establishments of Lima, PeruHuman space medicine: physiological performance and countermeasures to improve the astronaut's health author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista de la Facultad de Medicina Humana

Print version ISSN 1814-5469On-line version ISSN 2308-0531

Abstract

CABRERA, María Elena  and  PENA, Camila. Leukemia / Lymphoma T of the adult HTLV 1, a challenge for the clinic. Rev. Fac. Med. Hum. [online]. 2020, vol.20, n.2, pp.295-302. ISSN 1814-5469.  http://dx.doi.org/10.25176/rfmh.v20i2.2919.

Adult T-cell leukemia/lymphoma (ATL) is an aggressive disease of mature activated T cell caused by human T-cell lymphotropic virus type 1 (HTLV-1). ATL carries a bad prognosis due to intrinsic chemoresistance and severe immunosuppression. The aggressive ATL forms, acute and lymphoma, are treated with chemotherapy associated with antiretroviral agents (AZT/IFN) the acute form. However, they have failed to achieve an impact on survival, that ranges from 8-10 months, respectively. Patients with chronic and smoldering ATL forms, have a better prognosis, but long term survival is poor as well, when these patients are managed with a watchful waiting policy or with chemotherapy. Apparently, AZT/IFN seams to benefit these patients. Meanwhile, prevention of dissemination of HTLV-1, is a must in public health policies, performing screening in blood banks and a screening to pregnant women to reduce/avoid vertical transmission of the virus.

Keywords : Cell; ATLL Patient; HTLV-1 (source: MeSH NLM)..

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )